0 followers
Replimune is pioneering a new generation of cancer treatments called oncolytic immunotherapies.
Philip Astley-Sparke
Alexion Pharmaceuticals
35 followers
Freenome
5 followers
Summit Therapeutics
4 followers
Pivot Bio
2 followers
B Capital Group
43 followers
Darkhorse Tech
30 followers
Genesis Therapeutics
3 followers
Solugen
2 followers
Stonepeak Infrastructure Partners
4 followers
Inari
3 followers
Carisma Therapeutics
1 follower
Explore companies